Any regulatory changes to drug patents and pricing should be wary of stifling innovation, writes Neal Gerber Eisenberg lawyer Thomas Campbell | 4d
Thomas Campbell
Thomas Campbell
Thomas Campbell is a patent and trademark prosecution partner at Neal Gerber Eisenberg
- Firm:
- Neal Gerber Eisenberg
Copyright 2024 © The Global Legal Post. All Rights Reserved